Processa Pharmaceuticals, Inc. Share Price
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
01:30:00 26/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.180 USD | +0.46% |
|
+2.35% | -24.31% |
| Market Cap | 60.62L 51.94L 48.67L 44.46L 83.9L 58Cr 84.73L 5.74Cr 2.23Cr 29Cr 2.28Cr 2.23Cr 97Cr | P/E 2024 |
-0.23x | P/E 2025 | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | 5L 4L 4L 4L 7L 5Cr 7L 49.69L 19.35L 2.52Cr 19.7L 19.27L 8.36Cr | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
85.18% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Processa Pharmaceuticals, Inc.
| 1 day | +0.46% | ||
| 1 week | +2.35% | ||
| Current month | +1.40% | ||
| 1 month | -16.15% | ||
| 3 months | -17.74% | ||
| 6 months | +12.37% | ||
| Current year | -24.31% |
| 1 week | 2 |  | 2.28 |
| 1 month | 1.8 | | 3.11 |
| Current year | 1.67 | | 3.8 |
| 1 year | 1.67 | | 14.24 |
| 3 years | 1.67 | | 450 |
| 5 years | 1.67 | | 4,495.35 |
| 10 years | 1.67 | | 1,25,195.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Ng
CEO | Chief Executive Officer | 52 | 08/08/2023 |
Patrick Lin
IRC | Investor Relations Contact | 60 | 29/03/2011 |
Wendy Guy
ADM | Chief Administrative Officer | 61 | 04/10/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
David Young
CHM | Chairman | 73 | 29/03/2011 |
Justin Yorke
CHM | Chairman | 60 | 16/08/2022 |
Geraldine Pannu
BRD | Director/Board Member | 56 | 13/02/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/08/26 | Fiscal year | Chief Executive Officer | 3,200 | 0.1156% | ||
| 26/07/26 | Other | Chief Financial Officer | 11,883 | 0.4293% | ||
| 26/07/26 | Other | Chief Executive Officer | 9,384 | 0.3390% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.46% | +2.35% | -60.00% | -98.61% | 60.62L | |
| +3.31% | -3.53% | +71.28% | +104.57% | 6.91TCr | |
| +1.74% | +2.81% | +55.45% | +88.75% | 6.31TCr | |
| +1.09% | +24.51% | +2.86% | -4.20% | 2.83TCr | |
| -0.07% | -3.45% | -6.06% | +464.93% | 2.71TCr | |
| +7.41% | +13.08% | +58.57% | +17.04% | 2.55TCr | |
| +3.98% | +4.37% | +39.87% | -15.08% | 1.97TCr | |
| +1.02% | +5.67% | +273.94% | +420.34% | 1.92TCr | |
| +0.10% | +0.19% | +12.19% | +550.31% | 1.6TCr | |
| +3.98% | +8.41% | +46.83% | +160.78% | 1.35TCr | |
| Average | +2.30% | +3.74% | +49.49% | +168.88% | 2.81TCr | |
| Weighted average by Cap. | +2.52% | +2.95% | +59.34% | +157.97% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.19Cr -1.02Cr -95.15L -86.91L -1.64Cr -112.97Cr -1.66Cr -11Cr -4.37Cr -57Cr -4.45Cr -4.35Cr -188.76Cr | -1.36Cr -1.16Cr -1.09Cr -99.48L -1.88Cr -129.31Cr -1.9Cr -13Cr -5Cr -65Cr -5.09Cr -4.98Cr -216.05Cr |
| Net Debt | -11.18L -10L -9L -8L -15.47L -11Cr -15.62L -1.06Cr -41.21L -5.38Cr -41.97L -41.06L -18Cr | -55.37L -47.45L -44.46L -40.61L -76.64L -53Cr -77.4L -5.24Cr -2.04Cr -27Cr -2.08Cr -2.03Cr -88Cr |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/26/25 | $2.180 | +0.46% | 53,553 |
| 24/26/24 | $2.170 | +4.33% | 30,510 |
| 21/26/21 | $2.080 | -3.03% | 75,971 |
| 20/26/20 | $2.145 | -0.23% | 27,537 |
| 19/26/19 | $2.150 | +2.38% | 25,072 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PCSA Stock
Select your edition
All financial news and data tailored to specific country editions
